Back to today’s briefing

Story perspectives

GLP-1 Weight-Loss Drugs Linked to Rare Vision Issues

9/29/2025

36 5

Summary

Story summary

Two studies in type 2 diabetes linked GLP-1 weight-loss drugs to vision issues, but causation remains unproven.
35 cases of nonarteritic anterior ischemic optic neuropathy (NAION) were reported in GLP-1 users.
Diabetic retinopathy rose modestly with GLP-1 use, but severe events declined.
Findings in JAMA Network Open urge follow-up; risk about 1 in 10,000, regular eye exams advised.

1 of 1

Story summary

Two studies in type 2 diabetes linked GLP-1 weight-loss drugs to vision issues, but causation remains unproven.
35 cases of nonarteritic anterior ischemic optic neuropathy (NAION) were reported in GLP-1 users.
Diabetic retinopathy rose modestly with GLP-1 use, but severe events declined.
Findings in JAMA Network Open urge follow-up; risk about 1 in 10,000, regular eye exams advised.